Edesa Biotech, Inc. (EDSA)
2.74
-0.08
(-2.84%)
USD |
NASDAQ |
Oct 21, 16:00
2.74
0.00 (0.00%)
After-Hours: 18:39
Edesa Biotech Market Cap : 26.39M for Oct. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 27.17M |
| October 19, 2026 | 26.78M |
| October 16, 2026 | 24.76M |
| October 15, 2026 | 25.72M |
| October 14, 2026 | 25.53M |
| October 13, 2026 | 27.41M |
| October 12, 2026 | 28.32M |
| October 09, 2026 | 33.81M |
| October 08, 2026 | 35.26M |
| October 07, 2026 | 37.52M |
| October 06, 2026 | 35.84M |
| October 05, 2026 | 37.67M |
| October 02, 2026 | 37.18M |
| October 01, 2026 | 38.63M |
| September 30, 2026 | 40.56M |
| September 29, 2026 | 34.29M |
| September 28, 2026 | 35.16M |
| September 25, 2026 | 38.63M |
| September 24, 2026 | 38.82M |
| September 23, 2026 | 38.24M |
| September 22, 2026 | 39.21M |
| September 21, 2026 | 39.59M |
| September 18, 2026 | 39.88M |
| September 17, 2026 | 39.88M |
| September 16, 2026 | 37.28M |
| Date | Value |
|---|---|
| September 15, 2026 | 39.69M |
| September 14, 2026 | 39.83M |
| September 11, 2026 | 40.75M |
| September 10, 2026 | 44.89M |
| September 09, 2026 | 45.47M |
| September 08, 2026 | 45.56M |
| September 04, 2026 | 45.56M |
| September 03, 2026 | 45.85M |
| September 02, 2026 | 45.85M |
| September 01, 2026 | 46.05M |
| August 31, 2026 | 45.61M |
| August 28, 2026 | 44.51M |
| August 27, 2026 | 44.31M |
| August 26, 2026 | 47.59M |
| August 25, 2026 | 42.87M |
| August 24, 2026 | 42.39M |
| August 21, 2026 | 42.68M |
| August 20, 2026 | 45.85M |
| August 19, 2026 | 55.39M |
| August 18, 2026 | 55.01M |
| August 17, 2026 | 54.43M |
| August 14, 2026 | 51.54M |
| August 13, 2026 | 52.31M |
| August 12, 2026 | 51.06M |
| August 11, 2026 | 53.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProMIS Neurosciences, Inc. | 81.02M |
| Arrowhead Pharmaceuticals, Inc. | 8.303B |
| Oncolytics Biotech, Inc. | 64.09M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 1.961B |
Market Cap Related Metrics
| PEG Ratio | -0.0593 |
| Price to Book Value | 66.15 |
| Price | 2.74 |
| Earnings Yield | -61.74% |
| PEGY Ratio | -0.0593 |